Pharma’s Trial Problem: Outdated Systems, Broken Data, and the Coming AI Reset

In this thought leadership article, Erik Terjesen of Silicon Foundry explores how AI has the potential to transform clinical trials, while outdated data systems continue to limit progress. Although AI can help shorten timelines and improve decision-making, it is not a cure-all—it cannot fix flawed trial design, replace human oversight, or remove the need for regulatory rigor. The post Pharma’s Trial Problem: Outdated Systems, Broken Data, and the Coming AI Reset appeared first on GEN - Genetic Engineering and Biotechnology News.